
Last month, the FDA approved a gene therapy called Luxturna, which can treat a rare eye disease that causes blindness. Now the treatment has a price tag, CNBC reports. It will cost $425,000 per eye, and while $850,000 is steep, it's lower than the $1...
from Engadget RSS Feed http://ift.tt/2CxXMTP
via
IFTTT
No comments:
Post a Comment